Skip to main content

Day: May 4, 2020

Stingray publiera ses résultats financiers de l’exercice 2020

MONTRÉAL, 04 mai 2020 (GLOBE NEWSWIRE) — Le Groupe Stingray Inc. (TSX: RAY.A; RAY.B) publiera ses résultats financiers pour le quatrième trimestre ainsi que pour l’année fiscale se terminant le 31 mars 2020, le mercredi 3 juin 2020, après la fermeture des marchés financiers. La direction tiendra une téléconférence le lendemain, jeudi 4 juin 2020, à 10h00, heure normale de l’Est.Renseignements sur la téléconférence (en anglais seulement)Sur le site Web : www.stingray.comPar téléphone : (877) 223-4471 ou (647) 788-4922Téléconférence archivéeL’enregistrement de la téléconférence sera disponible deux heures après sa diffusion et jusqu’à minuit le 4 juillet, 2020 en composant le (800) 585-8367 ou le (416) 621-4642, en entrant le mot de passe 5454379p.À propos de StingrayLa société montréalaise Stingray (TSX : RAY.A; RAY.B)...

Continue reading

Gencor Releases Second Quarter Fiscal 2020 Results

ORLANDO, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (Nasdaq: GENC) announced today net revenues of $26.0 million for the quarter ended March 31, 2020 compared to $26.7 million for the quarter ended March 31, 2019.  Gross margins for the quarter ended March 31, 2020 were 28.2% compared with 37.2% for the quarter ended March 31, 2019.  The gross margins achieved in prior year’s quarter benefitted from an unusually strong pricing environment for plant and equipment sales. The current quarter’s gross margins of 28.2% reflect a more typical margin for the second quarter. Product engineering and development expenses decreased $134,000 to $689,000 for the quarter ended March 31, 2020. Selling, general and administrative (“SG&A”) expenses increased $87,000 to $2,561,000 for the quarter ended March 31, 2020. Increased...

Continue reading

Steve Madden Announces Change to Virtual-Only Format for 2020 Annual Meeting of Stockholders; Meeting Date Changed to June 5

LONG ISLAND CITY, N.Y., May 04, 2020 (GLOBE NEWSWIRE) — Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel for women, men and children, today announced that, due to the extraordinary circumstances of the ongoing coronavirus (COVID-19) pandemic and resulting restrictions on public gatherings, the Company will change its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) to a virtual-only format in order to help protect the health and well-being of its stockholders, employees, other usual meeting attendees and the community.  Due to scheduling availability, the Company is also changing the date and time of its 2020 Annual Meeting of Stockholders to Friday, June 5, 2020 at 2:00 p.m. Eastern Time.  There is no change to the items of business to be addressed...

Continue reading

Nordic American Tankers Ltd. (NYSE: NAT) – Dividend in Focus

 May 4, 2020 Dear Shareholders and Investors,Dear Sirs,In our message to you of March 24, 2020, we declared a dividend of 14 cents for 1Q 2020. This is double the dividend for 4Q 2019. For 1Q 2019, the declared dividend was 3 cents.We have now a dividend history of 91 consecutive quarters. Below is a link to our dividend table since the first payment in 1997, totalling close to USD 50 per share in dividend.NAT Dividends  CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTSMatters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives,...

Continue reading

PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call

SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced today that the Company will release its 2020 first quarter financial results on Friday, May 15, 2020, before the U.S. financial markets open.Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer, will host a conference call to discuss the results as follows:A replay of the conference call will be available for two weeks after the call’s completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International)....

Continue reading

Teleflex Announces Quarterly Dividend

WAYNE, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.  The dividend is payable June 15, 2020 to shareholders of record at the close of business on May 15, 2020.  Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency...

Continue reading

TCR² Therapeutics Announces Veteran Finance Executive Stephen Webster Joins its Board of Directors

CAMBRIDGE, Mass., May 04, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced the appointment of Stephen Webster to its Board of Directors. With nearly 30 years of biotechnology industry experience in raising capital, business development transactions and operations, Mr. Webster has played important roles as the Chief Financial Officer of Spark Therapeutics, Optimer Pharmacuticals and Adolor Corporation. In connection with Mr. Webster’s arrival, Mitchell Finer, Ph.D., will be stepping down from the Board of Directors effective May 4, 2020 but will continue to serve TCR2 in an advisory capacity.“We are delighted to welcome in another successful cell and gene therapy executive...

Continue reading

IPSOS: MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL ET RAPPORT FINANCIER ANNUEL 2019

Paris, le 4 mai 2020Modalités de mise à disposition du Document d’enregistrement universel 2019incluant le rapport financier annuelLe Document d’enregistrement universel d’Ipsos relatif à l’exercice clos le 31 décembre 2019, comprenant également le rapport financier annuel, a été déposé le 30 avril 2020 auprès de l’Autorité des Marchés Financiers (« l’AMF »), sous le numéro D.20-0418.Ce document peut être consulté ou téléchargé sur les sites internet d’Ipsos (https://www.ipsos.com/en/regulated-informations/fr) et de l’AMF (http://www.amf-france.org).Des exemplaires du Document d’enregistrement universel sont disponibles au siège de la société : 35, rue du Val de Marne – 75013 Paris.Le Document d’enregistrement universel inclut notamment :le rapport financier annuel 2019, constitué des comptes consolidés, des comptes annuels, du...

Continue reading

PRESS RELEASE: Business Finland has awarded a 1.3 million Euro R&D grant to SSH.COM for development of quantum-safe cryptography

For Immediate ReleaseHelsinki – May 4, 2020 – In connection with the national Post-Quantum Cryptography project, Business Finland has awarded SSH.COM a 1.3 million Euro grant for developing quantum-safe crypto technology. In addition to SSH.COM, the consortium comprises leading Finnish cybersecurity companies and research institutions, as well as international partners. Key national security agencies also participate in the project.The project is a part of the Digital Trust Finland program by Business Finland focused on driving collaboration between Finnish companies and the globally growing market of digital trust-based business models and solutions. The program supports also supports the assessment of the opportunities and threats posed by new technologies such as quantum computing.The project consists of several work packages that...

Continue reading

LEHDISTÖTIEDOTE: Business Finland on myöntänyt SSH.COM:ille 1,3 miljoonaa euroa tuo­te­­kehitysavustusta kvanttiturvallisen salausteknologian kehittämiseen

Välittömästi julkaisuvapaaHelsinki – 4.5.2020 – Osana kansallista Post-Quantum Cryptography -hanketta Business Finland on myöntänyt SSH.COM:ille 1,3 miljoonaa euroa tuotekehitysavustusta kvanttiturvallisten salausteknol­ogioiden kehittämiseen. Konsortioon kuuluu SSH.COM:in lisäksi joukko johtavia kotimaisia tietoturva-alan yrityksiä ja tutkimuslaitoksia sekä kansainvälisiä kumppaneita. Hankkeessa on mukana myös kansallisen turvallisuuden kannalta keskeisiä viranomaisia.Hanke on osa Business Finlandin Digital Trust -ohjelmaa, jonka tavoitteena on Suomen luottamus­pääomaa hyödyntäen kiihdyttää uusien innovaatioiden syntyä ja liiketoiminnan kasvua: turvallisuuden ja luottamuksen ratkaisuissa ja -palveluissa sekä ratkaisutoimittajien että hyödyntäjien näkökulmasta. Ohjelma tukee uusien teknologioiden, kuten kvanttilaskennan mahdollisuuksien...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.